Denali Therapeutics
DNLI
#3955
Rank
C$3.15 B
Marketcap
$21.72
Share price
1.23%
Change (1 day)
6.31%
Change (1 year)

EPS for Denali Therapeutics (DNLI)

EPS in 2023 (TTM): -$1.47

According to Denali Therapeutics 's latest financial reports the company's current EPS (TTM) is -$1.45. In 2022 the company made an earnings per share (EPS) of -$3.60 a decrease over its 2021 EPS that were of -$3.31.

EPS history for Denali Therapeutics from 2017 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-$1.47-59.11%
2022-$3.608.79%
2021-$3.31-712.82%
2020$0.54-118.93%
2019-$2.85402.44%
2018-$0.57-88.89%
2017-$5.11

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
-$2.58 77.14% Jersey
-$9.96 584.76%๐Ÿ‡บ๐Ÿ‡ธ USA
-$2.85 96.19%๐Ÿ‡บ๐Ÿ‡ธ USA
-$8.59 490.48%๐Ÿ‡ฌ๐Ÿ‡ง UK